Three Medical Science Training Program Students Awarded Prestigious NIH F30 Fellowships
2/15/2024
Three Medical Science Training Program (MSTP) students, Ryan Mulligan, Gustavo Pacheco, and Evan Lamb, were awarded prestigious F30 fellowships from the National Institutes of Health, totaling $446,595 this fiscal year.…
2/15/2024
Imre Noth, MD, the Dudley F. Rochester Professor of Medicine, and chief of the Division of Pulmonary and Critical Care Medicine, in the School of Medicine’s Department of Medicine, was…
Research in Motion: Karen Johnston, MD
2/15/2024
Our iTHRIV team helps researchers translate their most innovative ideas into actual treatments and cures for our patients. Innovative translational discoveries include things like gene therapy for rare diseases or…
UVA Health Leadership Institute Launches
2/6/2024
The UVA Health Leadership Institute (HLI) — a key pillar of the 2022-32 UVA Health strategic plan initiative of Best Place to Work — is off to an exciting start, hosting its…
Get to Know Ling Qi, PhD — Chair of the Department of Molecular Physiology and Biological Physics
2/6/2024
Ling Qi, PhD, was appointed chair of the Department of Molecular Physiology and Biological Physics effective September 1, 2023. Dr. Qi came to UVA from the University of Michigan Medical…
Research in Motion: Ahmad Jomaa, PhD
2/6/2024
The mitochondria is a cell stress sensor. It can sense stress at different stages of their cell cycle, and we're interested in that because that happens quite a lot in…
Get to Know Colin Derdeyn, MD — Chair of Radiology and Medical Imaging
1/31/2024
Colin Derdeyn, MD, joined UVA Department of Radiology and Medical Imaging, effective January 2, 2024. Dr. Derdeyn is a renowned physician scientist and national leader in improving stroke care of…
UVA Cancer Center Enrolls First Patient in National Phase 1 Immunotherapy Trial
1/31/2024
Led by Associate Professor of Hematology and Oncology Matthew Reilley, MD, the UVA Comprehensive Cancer Center (UVACCC) recently enrolled the first patient in a nationwide Phase 1 drug trial to…
